NASDAQ : TLSI

TriSalus Life Sciences, Inc. — Financial statements

Healthcare · Medical Devices · United States

Last price 3.7 USD (Oct 30, 2026, 4:00 PM EDT) · Market cap 227.83M

Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports

Financial statements

TriSalus Life Sciences, Inc. (TLSI) reported revenue of 45.08M USD (TTM). Five years of income statement, balance sheet, cash flow and ratios below.

Income statement

Fiscal year January - December; amounts in USD.

TTMFY2025FY2024FY2023FY2022FY2021
Revenue45.08M45.15M29.43M18.51M12.40M8.40M
Cost of Revenue6.41M6.96M4.10M2.60M2.26M1.19M
Gross Profit38.67M38.19M25.33M15.91M10.14M7.21M
Selling, General & Admin54.55M50.17M43.80M36.25M25.22M17.02M
Research & Development14.63M14.96M17.69M29.84M21.36M14.22M
Operating Expenses69.18M65.13M61.49M66.08M46.58M31.24M
Operating Income-30.51M-26.95M-36.16M-50.17M-36.44M-24.03M
Interest Expense-5.84M-5.54M-3.09M-16.00K-1.00K-1.76M
Interest & Investment Income968.00K555.00K404.00K431.00K180.00K
Other Non Operating Income (Expenses)3.40M-4.54M-2.42M-17.11M-10.92M-461.00K
EBT Excluding Unusual Items-31.98M-36.48M-41.27M-66.87M-47.18M-26.25M
Merger & Restructuring Charges-4.30M
Other Unusual Items3.78M-2.74M11.23M11.81M-2.59M
Pretax Income-28.20M-39.22M-30.04M-59.35M-47.18M-28.84M
Income Tax Expense13.00K7.00K6.00K9.00K9.00K3.00K
Net Income-28.21M-39.23M-30.05M-59.36M-47.19M-28.84M
Preferred Dividends & Other Adjustments29.04M30.46M3.19M4.24M2.83M
Net Income to Common-57.25M-69.69M-33.23M-63.60M-50.02M-28.84M
Shares Outstanding (Basic)50.01M37.90M25.33M9.40M309.61K8.86M
Shares Outstanding (Diluted)50.01M37.90M25.33M9.40M309.61K8.86M
EPS (Basic)-1.14-1.84-1.31-6.77-161.55-3.25
EPS (Diluted)-1.15-1.84-1.31-6.77-161.55-3.25
Free Cash Flow-23.28M-18.93M-41.19M-51.17M-32.97M-23.79M
Free Cash Flow Per Share-0.47-0.50-1.63-5.45-106.48-2.68
Gross Margin85.79%84.57%86.06%85.93%81.79%85.80%
Operating Margin-67.68%-59.68%-122.88%-271.06%-293.91%-286.06%
Profit Margin-127.00%-154.35%-112.92%-343.59%-403.42%-343.35%
Free Cash Flow Margin-51.65%-41.93%-139.95%-276.41%-265.91%-283.23%
EBITDA-29.95M-26.32M-35.42M-49.49M-36.04M-23.57M
EBITDA Margin-66.44%-58.29%-120.35%-267.36%-290.70%-280.54%
D&A For EBITDA560.00K626.00K744.00K684.00K398.00K464.00K
EBIT-30.51M-26.95M-36.16M-50.17M-36.44M-24.03M
EBIT Margin-67.68%-59.68%-122.88%-271.06%-293.91%-286.06%
Advertising Expenses1.40M500.00K1.30M

Balance sheet

Fiscal year January - December; amounts in USD.

TTMFY2025FY2024FY2023FY2022FY2021
Cash & Equivalents46.29M20.44M8.53M11.78M9.41M30.30M
Cash & Short-Term Investments46.29M20.44M8.53M11.78M9.41M30.30M
Receivables6.46M6.56M5.09M3.55M1.56M1.36M
Inventory4.21M3.08M4.05M2.54M1.47M1.29M
Prepaid Expenses2.79M2.17M3.01M2.99M4.77M2.18M
Total Current Assets59.74M32.24M20.67M20.86M17.21M35.13M
Property, Plant & Equipment2.63M2.67M2.88M3.27M3.61M1.80M
Other Intangible Assets802.00K794.00K
Other Long-Term Assets69.00K418.00K423.00K466.00K367.00K115.00K
Total Assets62.45M35.33M23.97M24.60M22.00M37.84M
Accounts Payable3.76M3.00M2.27M3.39M4.95M1.30M
Accrued Expenses7.11M8.00M7.32M10.53M6.38M4.97M
Current Portion of Leases244.00K167.00K216.00K351.00K370.00K
Current Income Taxes Payable100.00K34.00K31.00K
Other Current Liabilities58.00K234.00K383.00K389.00K20.66M104.00K
Total Current Liabilities11.17M11.50M10.23M14.69M32.36M6.37M
Long-Term Debt33.06M33.05M22.08M
Long-Term Leases1.12M1.23M1.33M1.24M1.59M
Other Long-Term Liabilities10.54M23.42M16.22M35.73M369.00K561.00K
Total Liabilities55.90M69.19M49.87M51.66M34.32M6.93M
Common Stock5.00K4.00K3.00K2.00K11.00K
Additional Paid-In Capital344.78M296.72M253.65M222.44M10.03M6.73M
Retained Earnings-338.23M-330.58M-279.55M-249.50M-186.36M-136.34M
Total Common Equity6.55M-33.86M-25.89M-27.07M-176.33M-129.60M
Shareholders' Equity6.55M-33.86M-25.89M-27.07M-12.32M30.90M
Total Liabilities & Equity62.45M35.33M23.97M24.60M22.00M37.84M
Total Debt34.43M34.44M23.63M1.59M1.96M
Net Cash (Debt)11.86M-14.00M-15.10M10.18M7.45M30.30M
Net Cash Per Share0.24-0.37-0.601.0824.073.42
Filing Date Shares Outstanding61.57M61.31M32.27M26.76M14.08M12.96M
Total Common Shares Outstanding61.47M50.00M31.28M26.41M14.08M10.72M
Working Capital48.57M20.75M10.44M6.17M-15.14M28.76M
Book Value Per Share0.11-0.68-0.83-1.02-12.53-12.09
Tangible Book Value6.55M-33.86M-25.89M-27.07M-177.13M-130.40M
Tangible Book Value Per Share0.11-0.68-0.83-1.02-12.58-12.16
Machinery3.21M4.34M3.80M3.87M3.15M
Construction In Progress248.00K331.00K598.00K
Leasehold Improvements1.57M772.00K772.00K772.00K783.00K

Cash flow statement

Fiscal year January - December; amounts in USD.

TTMFY2025FY2024FY2023FY2022FY2021
Net Income-28.21M-39.23M-30.05M-59.36M-47.19M-28.84M
Depreciation & Amortization560.00K626.00K744.00K684.00K398.00K464.00K
Other Amortization1.19M1.05M612.00K1.74M
Loss (Gain) From Sale of Assets4.00K120.00K23.00K44.00K310.00K-4.00K
Stock-Based Compensation10.71M9.13M5.44M1.40M368.00K109.00K
Provision & Write-off of Bad Debts141.00K163.00K187.00K
Other Operating Activities-6.83M8.06M-8.26M6.12M11.50M3.97M
Change in Accounts Receivable-1.07M-1.63M-1.72M-1.98M-200.00K-741.00K
Change in Inventory-398.00K971.00K-1.50M-1.07M-179.00K-725.00K
Change in Accounts Payable1.78M2.02M-4.38M2.84M5.25M3.17M
Change in Other Net Operating Assets-669.00K711.00K-1.94M751.00K-2.57M-1.84M
Operating Cash Flow-22.80M-18.01M-40.84M-50.58M-32.31M-22.70M
Capital Expenditures-480.00K-918.00K-345.00K-588.00K-655.00K-1.10M
Sale of Property, Plant & Equipment40.00K80.00K
Cash Acquisitions-1.00M-1.00M-1.00M
Sale (Purchase) of Intangibles-131.00K-161.00K
Investing Cash Flow-440.00K-838.00K-345.00K-1.59M-1.79M-2.26M
Long-Term Debt Issued10.00M25.00M45.00K
Long-Term Debt Repaid-81.00K-84.00K-87.00K-131.00K-1.35M
Net Debt Issued (Repaid)-36.00K9.92M24.92M-87.00K-131.00K-1.30M
Issuance of Common Stock44.86M22.91M15.61M179.00K94.00K54.00K
Other Financing Activities-2.13M-2.07M-2.59M35.72M
Financing Cash Flow42.69M30.76M37.94M54.63M13.46M50.77M
Net Cash Flow19.45M11.91M-3.25M2.46M-20.64M25.81M
Free Cash Flow-23.28M-18.93M-41.19M-51.17M-32.97M-23.79M
Free Cash Flow Margin-51.65%-41.93%-139.95%-276.41%-265.91%-283.23%
Free Cash Flow Per Share-0.47-0.50-1.63-5.45-106.48-2.68
Levered Free Cash Flow-10.88M-8.76M-25.47M-48.81M-151.00K-24.49M
Unlevered Free Cash Flow-8.42M-6.34M-24.15M-48.80M-150.38K-25.13M
Cash Interest Paid4.43M3.70M1.75M18.00K18.00K
Cash Income Tax Paid16.00K18.00K14.00K9.00K3.00K
Change in Working Capital-357.00K2.07M-9.55M537.00K2.30M-131.00K

Ratios

Fiscal year January - December; amounts in USD.

TTMFY2025FY2024FY2023FY2022FY2021
Market Capitalization227.83M348.75M152.77M222.38M313.44M308.75M
Enterprise Value215.96M360.19M164.93M202.69M
Last Close Price3.706.985.018.4510.039.88
PS Ratio5.057.725.1912.0125.2836.75
PB Ratio34.72-10.30-5.90-8.22-25.439.99
EV/Sales Ratio4.797.985.6010.95
Debt / Equity Ratio5.26-1.02-0.91-0.06-0.16
Net Debt / Equity Ratio-1.81-0.41-0.580.380.60-0.98
Net Debt / EBITDA Ratio0.40-0.53-0.430.210.211.29
Net Debt / FCF Ratio0.51-0.74-0.370.200.231.27
Asset Turnover0.871.521.210.800.410.37
Inventory Turnover1.601.961.251.301.631.28
Quick Ratio4.722.351.331.040.344.97
Current Ratio5.352.802.021.420.535.51
Return on Equity (ROE)-507.96%
Return on Assets (ROA)-36.75%-56.80%-93.08%-134.61%-76.13%-65.35%
Return on Capital Employed (ROCE)-59.50%-113.10%-263.20%-506.30%351.70%-76.40%
Earnings Yield-31.03%-11.25%-19.67%-26.70%-15.05%-9.34%
FCF Yield-10.22%-5.43%-26.96%-23.01%-10.52%-7.71%
Buyback Yield / Dilution-73.15%-49.61%-169.61%-2,934.71%96.51%-15.52%